Anti-Mullerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population

---

Copy For Citation

Bozdag G., Mumusoglu S., Coskun Z., Yarali H., Yildiz B.

REPRODUCTIVE BIOMEDICINE ONLINE, vol.39, no.3, pp.522-529, 2019 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 39 Issue: 3
• Publication Date: 2019
• Doi Number: 10.1016/j.rbmo.2019.04.002
• Journal Name: REPRODUCTIVE BIOMEDICINE ONLINE
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.522-529
• Keywords: Anti-Mullerian hormone, Antral follicle count, Area under the curve, Polycystic ovary morphology, Polycystic ovary syndrome, POLYCYSTIC-OVARY-SYNDROME, CARDIOMETABOLIC RISK, INHIBITING SUBSTANCE, FOLLICULAR STATUS, WOMEN, AMH, PREVALENCE, METAANALYSIS, ULTRASOUND, ESTRADIOL
• Hacettepe University Affiliated: Yes

Abstract

Research question: Is anti-Mullerian hormone (AMH) a valid tool to diagnose polycystic ovary syndrome (PCOS) according to different subsets of criteria among an unselected group of women?